Revenue: Below the engineered breaking point of $5.5 million per quarter. Net Loss: Reported a net loss for the quarter. Sales Performance: Lower year-over-year sales into China; delayed antigen sales ...
Good morning, everyone. Thanks for joining us today. We have an update with Microbix, who just put out their Q2 numbers this morning. So hopefully, everyone's had a chance to review those. With me on ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
MISSISSAUGA, ON / ACCESS Newswire / May 7, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file ...
Presenting Results of Novel Product for Quality Control of RNA-based Assays MISSISSAUGA, ON / ACCESS Newswire / April 15, 2026 / Microbix Biosystems Inc. (TSX: MBX)(OTCQX:MBXBF, Microbix), a life ...
MISSISSAUGA, ON / ACCESS Newswire / April 16, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending ...
MISSISSAUGA, ON / ACCESS Newswire / April 27, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix), a life sciences innovator, manufacturer, and exporter, announces that one of its clients ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
MISSISSAUGA, ON / ACCESS Newswire / March 10, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix ®), a life sciences innovator, manufacturer, and exporter, announces that the contract ...
All right. I think we can get started. Good morning, everyone. Thanks for joining us. We have an update from Microbix to discuss the Fiscal Q1 2026 Results. A sequential improvement ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.